MRCRO

Cardiometabolic Diseases

Our research in cardiometabolic disorders explicitly targets cardiovascular diseases & diabetes in Pakistan, where an estimated 33 million people are living with type 2 diabetes, with a 26.7% prevalence rate in adults.*

Source :* Federation, I. D. (2021). Diabetes in Pakistan (2021). Retrieved from International Diabetes Federation: https://idf.org/our-network/regions-and-members/middle-east-and-north-africa/members/pakistan/

Real-World Data (RWD) Experiences

Metrics Research contributions to these Real-World Data (RWD) studies provided comprehensive insights into patient experiences, treatment outcomes, and healthcare trends, supporting sponsors in making informed decisions.

300+
Enrollment of subjects with hypertension.
Subjects enrolled undergoing implantation of a cardiac stent.
300+
Inclusion of diabetic patients for real-world insights on marketed insulin.
180+
700+
Patients enrolled for the evaluation of Lp(a).

Bio-equivalence Studies

Conducted multiple BE studies on single and combination pharmacotherapeutic molecules.

Experiences in Diabetes Mellitus 

Multi-center observational study on diabetes.

Provided services for the statistical analysis of real-world data on metabolic disorders, including diabetes.

Conducted Bioequivalence (BE) studies on anti-diabetic medication.

Expert medical writing services related to a range of cardiometabolic diseases, including diabetes, tailored to the study-specific needs of sponsors.

Trial Insurance

  • Customized coverage for clinical trial participant.
  • Risk assessment and tailored insurance solutions
  • Compliance with international and national level regulations.

IT Solutions

  • Enabling collaborations with the EDC tool vendor.
  • Providing IT-enabled data management support.
  • Integrating data from various sources to facilitate efficient data management.
  • Monitoring site performance for optimizing the use of resources.
  • Maintaining audit trails for tracking changes to ensure data integrity through EDC tools.

Specimen Shipment & Handling

  • Secure and compliant handling of biological specimens.
  • Temperature-controlled packaging and shipping.
  • Collaborative services with global logistics network for specimen transportation.
  • Ensuring regulatory compliance for international shipments.
  • Expertise in managing various specimen types, including blood, tissue, and urine.

Clinical Trial Ancillary Supplies

  • Enabling the sponsors with the ancillary supplies for clinical trials.
  • Comprehensive inventory management and tracking.
  • Customizing supply chain solutions to meet trial-specific needs.
  • Ensuring timely supply services.
  • Providing cost efficient solutions to optimize trial budgets.

IP/ Placebo / Comparator Sourcing

  • In-house services for sourcing of Investigational Products, comparators, and placebos.
  • Collaboration with suppliers and manufacturers.
  • Experienced team for procurement and logistics management.

Central Laboratory Testing

  • Collaborative services for diagnostic and clinical testing.
  • Enabling sponsors to evaluate diverse range of clinical endpoints through diagnostic tests.
  • Meeting quality standards and regional regulatory compliance.
  • Standardized procedures for authentic and credible outcomes.

Percentage Of Total Contributions

Head Office:

Karachi: Plot No. B-10, Block 16, WCHS, KDA Scheme No.24, Gulshan E Iqbal, Karachi – Pakistan.

Regional Office:

Flat No. 2, first floor, 2-C Plaza ( First floor of M.A Dental Clinic) Pakeeza Market, Sector I-8/4, Islamabad, Pakistan

Regional Presence:

  • Sindh
  • Punjab
  • Balochistan
  • Khyber Pakhtunkhwa